miR-338 and miR-30a are EYA2 regulators, and their downregulation increases EYA2 expression in breast cancer, and its reduction and epidermal growth factor receptor (EGFR) downregulation have been associated with lung metastasis [229, 230]. Here, EGFR is linked to breast cancer.